Active
InvVax
Nanoparticle vaccine developer targeting pertussis and P. aeruginosa
Manufacturers
- Country
- Czechia
- Founded
- —
- HQ City
- —
- HQ Address
- Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1RQ, United Kingdom
- —
- Phone
- —
- Website
- https://www.inv-vax.com/
About
InvVax develops nanoparticle vaccines targeting pertussis (whooping cough) and Pseudomonas aeruginosa lung infections, utilizing novel antigen display technologies.
Vaccines
No data available
FAQ
No FAQ items available.